TARDBP and Alzheimer disease: Our key findings include the following: (1) at least 9.7% of AD patients without LB had parkinsonism, (2) parkinsonism was correlated with reduced nigral neuron density, and (3) TDP‐43 pathology was implicated in nigral neurodegeneration in AD.